Drugs / BM-MNC
BM-MNC
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/25 trials · 1 met primary | ||||||
| Phase 1/2 | NCT03943940 | Apr → Dec 2019 | type 2 diabetes mellitus | Van Hanh General Hospital | Unknown | No outcome recorded |
| Phase 1/2 | NCT04501341 | Mar 2016 → Dec 2021 | type 2 diabetes mellitus | Indonesia University | Unknown | No outcome recorded |
| Phase 1/2 | NCT00767260 | Mar 2008 → Mar 2012 | type 2 diabetes mellitus | Fuzhou General Hospital | Completed | Met primary |
| Phase 1/2 | NCT00713934 | Jan 2008 → Jan 2009 | cirrhosis of liver, disease related to hematopoietic stem cell transplant | Royan Institute | Completed | No outcome recorded |
| Phase 1/2 | NCT00677404 | Jan 2008 → Oct 2009 | limb ischemia, peripheral arterial disease | Royan Institute | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT02454231 Comparator | Sep 2009 → May 2015 | limb ischemia | University of Florence | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BM MNC | “autologous BM MNC [without G-CSF (MNC-G-CSF) or combined with G-CSF administration for 5 days following transplantation (MNC+G-CSF)]” PMID 20078390 ↗ Oct 2010 |
| Known as | BM-MNCs | “The investigators designed a randomized clinical trial (stem cell emergency life threatening arteriopathy or SCELTA) to compare the therapeutic efficacy of the auto-transplant...” NCT02454231 ↗2“Autologous bone marrow mononuclear cells (BM-MNCs) and allogeneic umbilical cord tissue-derived mesenchymal stem cells (UC-MSCs) under sterile conditions to treat this disease.” NCT03943940 ↗ “Bone-marrow mononuclear cells (BM-MNCs) and umbilical-cord tissue-derived mesenchymal stem cells (UC-MSCs) via its immunomodulatory properties” NCT04501341 ↗ |
| Known as | Bone-marrow mononuclear cells | “Autologous bone marrow mononuclear cells (BM-MNCs) and allogeneic umbilical cord tissue-derived mesenchymal stem cells (UC-MSCs) under sterile conditions to treat this disease.” NCT03943940 ↗2“Autologous bone-marrow mononuclear cells infused to the main blood vessels that supply the pancreas” NCT04501341 ↗ “implantation of autologous bone marrow mononuclear cells” PMID 20078390 ↗ Oct 2010 |
| Modality | Cell therapy | “autologous transplantation of mononuclear cells” NCT00677404 ↗ |
| Route | Intramuscular | “is intramuscularly injected” NCT00677404 ↗ |